| Franklin Templeton International Services S.à r.l. | RV Sector Biotecnología | 47,91% | 3,03% | | | |
| Pictet Asset Management (Europe) SA | RV Sector Biotecnología | 45,82% | 2,52% | | | |
| Candriam | RV Sector Biotecnología | 37,22% | 5,73% | | | |
| Janus Henderson Investors | RV Sector Biotecnología | 31,94% | 13,68% | | | |
| Welzia Management SGIIC | RV Sector Biotecnología | 30,79% | — | | | |
| Sectoral Asset Management Inc | RV Sector Biotecnología | 24,51% | 2,12% | | | |
| Polar Capital LLP | RV Sector Biotecnología | 24,15% | 12,46% | | | |
| Medical Strategy GmbH | RV Sector Biotecnología | 22,16% | 5,31% | | | |
| Erste Asset Management GmbH | RV Sector Biotecnología | 21,25% | 3,61% | | | |
| JPMorgan Asset Management (Europe) S.à r.l. | RV Sector Biotecnología | 20,68% | -10,11% | | | |
| UBS Asset Management (Europe) S.A. | RV Sector Biotecnología | 19,86% | 2,67% | | | |
| DNB Asset Management SA | RV Sector Biotecnología | 11,76% | — | | | |
| DWS Investment GmbH | RV Sector Biotecnología | 11,47% | 3,82% | | | |
| Abante Asesores Gestión SGIIC | RV Sector Biotecnología | 9,93% | -6,66% | | | |
| Andbank Wealth Management SGIIC | RV Sector Biotecnología | 5,33% | — | | | |
